These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31210735)

  • 1. Rev-erbs and Glia-Implications for Neurodegenerative Diseases.
    Griffin P; Dimitry JM; Musiek ES
    J Exp Neurosci; 2019; 13():1179069519853233. PubMed ID: 31210735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian clock protein Rev-erbα regulates neuroinflammation.
    Griffin P; Dimitry JM; Sheehan PW; Lananna BV; Guo C; Robinette ML; Hayes ME; Cedeño MR; Nadarajah CJ; Ezerskiy LA; Colonna M; Zhang J; Bauer AQ; Burris TP; Musiek ES
    Proc Natl Acad Sci U S A; 2019 Mar; 116(11):5102-5107. PubMed ID: 30792350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological activation of REV-ERBα represses LPS-induced microglial activation through the NF-κB pathway.
    Guo DK; Zhu Y; Sun HY; Xu XY; Zhang S; Hao ZB; Wang GH; Mu CC; Ren HG
    Acta Pharmacol Sin; 2019 Jan; 40(1):26-34. PubMed ID: 29950615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Putatively Specific Synthetic REV-ERB Agonist SR9009 Inhibits IgE- and IL-33-Mediated Mast Cell Activation Independently of the Circadian Clock.
    Ishimaru K; Nakajima S; Yu G; Nakamura Y; Nakao A
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31847374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of nuclear receptor REV-ERBs suppresses production of pronociceptive molecules in cultured spinal astrocytes and ameliorates mechanical hypersensitivity of inflammatory and neuropathic pain of mice.
    Morioka N; Kodama K; Tomori M; Yoshikawa K; Saeki M; Nakamura Y; Zhang FF; Hisaoka-Nakashima K; Nakata Y
    Brain Behav Immun; 2019 May; 78():116-130. PubMed ID: 30682503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian Clock Genes REV-ERBs Inhibits Granulosa Cells Apoptosis by Regulating Mitochondrial Biogenesis and Autophagy in Polycystic Ovary Syndrome.
    Sun L; Tian H; Xue S; Ye H; Xue X; Wang R; Liu Y; Zhang C; Chen Q; Gao S
    Front Cell Dev Biol; 2021; 9():658112. PubMed ID: 34422794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of nuclear receptor REV-ERBs suppresses inflammatory responses in spinal microglia.
    Morioka N; Kodama K; Tsuruta M; Hashizume H; Kochi T; Nakamura Y; Zhang FF; Hisaoka-Nakashima K
    Neurochem Int; 2021 Dec; 151():105216. PubMed ID: 34710533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Characterization of Circadian Nuclear Receptors REV-ERBα and REV-ERBβ in Human Osteosarcoma Cell Cultures.
    Cho H; Yun A; Kim J; Park E; Jung JW; Chung S; Son GH
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglial REV-ERBα regulates inflammation and lipid droplet formation to drive tauopathy in male mice.
    Lee J; Dimitry JM; Song JH; Son M; Sheehan PW; King MW; Travis Tabor G; Goo YA; Lazar MA; Petrucelli L; Musiek ES
    Nat Commun; 2023 Aug; 14(1):5197. PubMed ID: 37626048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. REV-ERB agonism suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss partially via FABP4 upregulation.
    Song C; Tan P; Zhang Z; Wu W; Dong Y; Zhao L; Liu H; Guan H; Li F
    FASEB J; 2018 Jun; 32(6):3215-3228. PubMed ID: 29401617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. REV-ERBβ is required to maintain normal wakefulness and the wake-inducing effect of dual REV-ERB agonist SR9009.
    Amador A; Kamenecka TM; Solt LA; Burris TP
    Biochem Pharmacol; 2018 Apr; 150():1-8. PubMed ID: 29355503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian REV-ERBs repress
    Dierickx P; Zhu K; Carpenter BJ; Jiang C; Vermunt MW; Xiao Y; Luongo TS; Yamamoto T; Martí-Pàmies Í; Mia S; Latimer M; Diwan A; Zhao J; Hauck AK; Krusen B; Nguyen HCB; Blobel GA; Kelly DP; Pei L; Baur JA; Young ME; Lazar MA
    Nat Cardiovasc Res; 2022 Jan; 1(1):45-58. PubMed ID: 35036997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of transcriptional control by Rev-erbα: An energetic foundation for reconciling structure and binding with biological function.
    Vaissière A; Berger S; Harrus D; Dacquet C; Le Maire A; Boutin JA; Ferry G; Royer CA
    Protein Sci; 2015 Jul; 24(7):1129-46. PubMed ID: 25969949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of N-terminal regions of REV-ERBs regulates their intracellular localization.
    Ohba Y; Tei H
    Genes Cells; 2018 Apr; 23(4):285-293. PubMed ID: 29508494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological and Genetic Modulation of REV-ERB Activity and Expression Affects Orexigenic Gene Expression.
    Amador A; Wang Y; Banerjee S; Kameneka TM; Solt LA; Burris TP
    PLoS One; 2016; 11(3):e0151014. PubMed ID: 26963516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of nuclear receptor REV-ERBs regulates tumor necrosis factor-induced expression of proinflammatory molecules in C6 astroglial cells.
    Morioka N; Tomori M; Zhang FF; Saeki M; Hisaoka-Nakashima K; Nakata Y
    Biochem Biophys Res Commun; 2016 Jan; 469(2):151-7. PubMed ID: 26616049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A specific and unusual nuclear localization signal in the DNA binding domain of the Rev-erb orphan receptors.
    Chopin-Delannoy S; Thénot S; Delaunay F; Buisine E; Begue A; Duterque-Coquillaud M; Laudet V
    J Mol Endocrinol; 2003 Apr; 30(2):197-211. PubMed ID: 12683943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of atherosclerosis by synthetic REV-ERB agonist.
    Sitaula S; Billon C; Kamenecka TM; Solt LA; Burris TP
    Biochem Biophys Res Commun; 2015 May; 460(3):566-71. PubMed ID: 25800870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct and indirect suppression of interleukin-6 gene expression in murine macrophages by nuclear orphan receptor REV-ERBα.
    Sato S; Sakurai T; Ogasawara J; Shirato K; Ishibashi Y; Oh-ishi S; Imaizumi K; Haga S; Hitomi Y; Izawa T; Ohira Y; Ohno H; Kizaki T
    ScientificWorldJournal; 2014; 2014():685854. PubMed ID: 25401152
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.